Bijal Parikh, MD, PhD

Assistant Professor, Pathology & Immunology

 

Additional Titles

  • Medical Director, Molecular Diagnostics Laboratory
  • Associate Medical Director, Molecular Infectious Disease Laboratory
  • Associate Medical Director, HLA Laboratory
  • Associate Program Director, Molecular Genetic Pathology Fellowship

Education

  • BS: Rutgers University, New Brunswick, NJ (1998)
  • PhD: Rutgers University, New Brunswick, NJ (2004)
  • MD: Robert Wood Johnson Medical School-Rutgers University, Piscataway, NJ (2006)
  • Residency, Clinical Pathology: Washington University, St. Louis, MO (2010)
  • Fellowship, Molecular Genetic Pathology: Washington University, St. Louis, MO (2018)

Board Certifications

  • Missouri Medical License
  • American Board of Pathology in Clinical Pathology, 2011
  • American Board of Pathology in Molecular Genetic Pathology, 2019

Recognition

  • Outstanding Research Award in Molecular Pathology/Pharmacogenomics, American Association for Clinical Chemistry Annual Meeting, 2009

  • Paul E. Strandjord Young Investigator Award, Academy of Clinical Laboratory Physicians and Scientists Annual Meeting, 2009, 2010

  • Infectious Diseases Training Grant (T32-A1007172), 2010

  • Rheumatology Training Grant (T32-AR007279), 2011-2012

  • Chair’s Special Recognition Award, COVID Clinical Hero, Washington University Department of Pathology and Immunology, 2020

  • Outstanding Achievements in Quality Improvement Award, Washington University Department of Pathology and Immunology, 2020

Research Interests

My clinical research centers on aspects of laboratory testing involving viral, immunologic, and molecular diagnostics, with a specific focus on the implementation of next-generation sequencing approaches. My basic science interests explore mechanisms governing host-pathogen interactions with ongoing research projects around the development of a murine cytomegalovirus model study innate immune control by natural killer cells and trafficking of virus during neonatal infection.

Publications

Selected Publications:

Raju S., Anderson N.W., Robinson E., Squires C., Wallace M.A., Burnham C.D, and Parikh B.A. Comparison of Six SARS-CoV-2 Molecular Methods and Correlation with the Cycle Threshold Distribution in Clinical Specimens. J Appl Lab Med. 2021 Jul 20:jfab086.
Parikh, B.A. and Farnsworth W.C. Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic. Best Pract Res Clin Rheumatol, 2021. 101660. doi: 10.1016/j.berh.2021.101660. PMID: 33518410
Tahan S., Parikh B.A., Droit L, Wallace M., Burnham C.D., and Wang D. SARS-CoV-2 E gene variant alters analytical sensitivity characteristics of viral detection using a commercial RT-PCR assay. J. Clin. Microbiol. 2021. 59(7):e0007521. PMID: 33903167
Parikh B.A., Bern M.D., Piersma S.J., Yang L., Beckman D.L., Poursine-Laurent J., Plougastel-Douglas B., and Yokoyama W.M. Control of viral infection by natural killer cell inhibitory receptors. Cell Rep. 2020. 32:107969. PMID: 32726632
Parikh B.A., Love-Gregory L., Duncavage E.J., and Heusel J.W. Identification of challenges and a framework for implementation of the AMP/ASCO/CAP classification guidelines for reporting somatic variants. 2020. Pract Lab Med. 21:e00170. PMID: 32548229
Liu C., Duffy B.F., Weimer E.T., Montgomery M.C., Jennemann J.E., Hill R., Phelan D., Lay L., Parikh B.A. Performance of a multiplexed amplicon-based next-generation sequencing assay for HLA typing. PLoS One. 2020;15:e0232050. PMID: 32324777
Parikh B.A., Piersma S.J., Pak-Wittel M.A., Yang L., Schreiber R.D., and Yokoyama W.M. Dual requirement of cytokine and activation receptor triggering for cytotoxic control of murine cytomegalovirus by NK cells. PLoS Pathog. 2015 11:e1005323. PMID: 26720279
Parikh, B.A., Beckman, D.L., Patel, S.J., White, J.M., and Yokoyama, W.M. Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing. PLoS One. 2015; 10:e0116484. PMID: 25587897

Assistant
Christine Berry
314-362-2207
berryc@wustl.edu
Office Location:
 LGM, Suite 5806